Search through
BDH succinate salt (CAS 183388-64-9) is a critical chiral building block in the API intermediates market, primarily utilized for the synthesis of complex protease inhibitors such as Ritonavir and Lopinavir. As a bulk chemical supplier, we observe that CDMOs are increasingly demanding high-purity fine chemicals (Pharma/API purity 99%) to ensure stringent stereochemical control and to meet escalating global regulatory standards for antiretroviral therapies. (2S,3S,5S)-2-Amino-3-hydroxy-5-(tert-butyloxycarbonylamino)-1,6-diphenylhexane succinate (CAS 183388-64-9) serves as a sophisticated intermediate in medicinal chemistry, where its unique BOC-protected amino and hydroxyl functionality enables efficient peptide-like coupling in drug discovery. Current market trends show a significant shift toward custom synthesis services that can provide traceable supply chains and robust analytical validation to mitigate the risks associated with multi-step synthesis of high-value pharmaceuticals (Pharma/API purity 99%). tert-Butyl ((2S,4S,5S)-5-amino-4-hydroxy-1,6-diphenylhexan-2-yl)carbamate succinate (CAS 183388-64-9) is an essential component for the production of advanced therapeutics targeting viral enzymes and metabolic disorders. The industry is moving toward audited manufacturing sites and sustainable sourcing strategies, reinforcing the demand for a reliable bulk chemical supplier capable of delivering high-quality batches (Pharma/API purity 99% | General Industry purity 98%) to facilitate seamless scale-up from pilot to commercial manufacturing. We are an established global intermediates supplier with >= 99% purity, ensuring minimal carry-over of impurities in the final API. We offer a broad range of pharmaceutical intermediates for API manufacturers and finished formulators, providing comprehensive analytical support (HPLC/NMR/MS), (2S,3S,5S)-5-tert-Butyloxycarbonylamino-2-amino-3-hydroxy-1,6-diphenylhexane succinate COA/TDS/SDS, region-specific regulatory support, reliable lead times, and worldwide supply chain capabilities.
BDH succinate salt (CAS 183388-64-9) is a critical chiral building block in the API intermediates market, primarily utilized for the synthesis of complex protease inhibitors such as Ritonavir and Lopinavir. As a bulk chemical supplier, we observe that CDMOs are increasingly demanding high-purity fine chemicals (Pharma/API purity 99%) to ensure stringent stereochemical control and to meet escalating global regulatory standards for antiretroviral therapies. (2S,3S,5S)-2-Amino-3-hydroxy-5-(tert-butyloxycarbonylamino)-1,6-diphenylhexane succinate (CAS 183388-64-9) serves as a sophisticated intermediate in medicinal chemistry, where its unique BOC-protected amino and hydroxyl functionality enable...
Chemical Properties & Specifications
P260, P261, P264+P265, P271, P273, P280, P304+P340, P305+P354+P338, P317, P319, P391, P403+P233, P405, and P501
Eye Dam. 1 (96.2%)
STOT SE 3 (13.5%)
This compound serves as a critical core building block in the synthesis of Ritonavir, a selective HIV protease inhibitor, and acts as a chiral intermediate for various bioactive molecules
It is utilized in peptide chemistry to protect amino groups, allowing for the efficient construction of complex peptide sequences and biomolecules
The compound is used in bioconjugation for targeted drug delivery systems in cancer therapy and serves as an analytical standard for the quantification and characterization of similar chemical entities.
(2S,3S,5S)-5-tert-Butyloxycarbonylamino-2-amino-3-hydroxy-1,6-diphenylhexane succinate, also known as BDH succinate salt, is a chiral building block and key intermediate used primarily in the synthesis of the HIV protease inhibitor Ritonavir.
This compound is widely utilized in the pharmaceutical and biotechnology industries for drug development and medicinal chemistry research.
It is compatible with organic solvents used in synthetic chemistry and is typically formulated as an active pharmaceutical ingredient intermediate or impurity standard.
Standard specifications include CAS number 183388-64-9, high purity (typically ≥99%), and documentation such as COA, TDS, impurity report, and regulatory compliance documents.
Scimplify has capabilities for global distribution and custom synthesis through an integrated network of manufacturers and logistics partners with reliable lead time.
The product is export ready with a standard MOQ starting from 100 kgs, with lead times for international customers depending on the shipping destination and regulatory requirements.
